are compounded glp 1 fda approved issued 25 warning letters to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Despite FDA ruling, compounded GLP-1s

Clinical Trials Only 2 clinical trials relating to GLP-1RAs have been published to date, with 1 of these published as a conference abstract

Many patients can continue GLP-1 receptor agonists

The approval of OZEMPIC allows us to address issues within the cardiovascular-kidney-metabolic syndrome, which impacts millions of adults and could lead to severe outcomes if not treated, stated Anna Windle, PhD, Senior Vice President of Clinical Development, Medical & Regulatory Affairs at Novo Nordisk

The science behind biomimetic GLP-1 supplements is promising, but this category will live or die by evidence, not enthusiasm

As use of these medications grows, policymakers, payers, healthcare providers, and patients face an important question: what helps ensure that the benefits of GLP-1 therapy are sustained over time